stockrowCapricor Therapeutics, Inc. (CAPR) vs Gyre Therapeutics, Inc. (GYRE)
- Capricor Therapeutics, Inc. CAPR 9.90 +10.00%
- Gyre Therapeutics, Inc. GYRE 4.64 −2.52%
Capricor Therapeutics, Inc. and Gyre Therapeutics, Inc. are both Biotechnology companies. Capricor Therapeutics, Inc. is the larger, with a market value of $572.7M against $493.1M — 1.2× the size. Gyre Therapeutics, Inc. grew revenue faster over the last twelve months: 13.5% against −11.6%. Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −21.5%) and the lower return on invested capital (−1,019.7% vs −8.51%). Across the 16 metrics below, Gyre Therapeutics, Inc. leads on 9 and Capricor Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | CAPR | GYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 91.71% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | (21.46%) | 0.00% |
| Free cash flow margin | 0.00% | (19.94%) | 0.00% |
| Return on equity | (73.70%) | (18.54%) | (50.82%) |
| Return on assets | (51.53%) | (14.49%) | (46.04%) |
| Return on invested capital | (1,019.73%) | (8.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack